Automox vs AbbVie

About

Automox is a cloud-native IT endpoint management and patching platform that automates OS and third-party software patching, configuration management, and vulnerability remediation across Windows, macOS, and Linux endpoints — enabling IT teams to maintain security compliance and reduce patch lag without the complexity of on-premises patch management infrastructure. Founded in 2015 and headquartered in Boulder, Colorado, Automox has raised over $130 million and serves IT and security teams at mid-market and enterprise organizations who need to manage thousands of endpoints across distributed workforces.\n\nAutomox's cloud-native architecture means there is no on-premises infrastructure required — a lightweight agent on each endpoint connects directly to the Automox cloud platform, enabling patch deployment, configuration enforcement, and software installation from a single dashboard regardless of whether endpoints are on corporate networks or remote. The platform's Worklets feature enables custom automation scripts that can remediate specific vulnerabilities, enforce configuration baselines, or execute IT operations tasks across the entire endpoint fleet in minutes.\n\nIn 2025, Automox competes in the endpoint management market against Ivanti (acquired Patch for Windows/LANDESK), Tanium, ManageEngine Patch Manager, and Microsoft Intune for Windows patch management. The market has grown significantly as hybrid and remote work models made traditional VPN-dependent patch management inadequate, and as ransomware attacks exploiting unpatched vulnerabilities increased. Automox's 2025 strategy focuses on expanding its automated vulnerability remediation capabilities (patching faster after CVEs are published), deepening its integration with vulnerability scanners (Tenable, Rapid7), and growing in the mid-market IT security segment.